Clinical Trial Update: S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This document notes the completion of SWOG trial S9714, a Phase 2 study of paclitaxel for stage IIIB or stage IV non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED